Is caspase-8 a neuroendocrine lung tumor supressor?

Cancer Biology and Therapy

Volumn 1, Issue 1, 2002, Pages 70-71

  Mazumder, Suparna ^a   Almasan, Alexandru ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASP8 PROTEIN, HUMAN; CASP9 PROTEIN, HUMAN; CASPASE; CASPASE 8; CASPASE 9; TUMOR PROTEIN;

APOPTOSIS; CELL CULTURE; DNA METHYLATION; ENZYMOLOGY; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; NEUROBLASTOMA; NOTE; PATHOLOGY; PHYSIOLOGY; SMALL CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CASPASE 8; CASPASE 9; CASPASES; DNA METHYLATION; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; NEUROBLASTOMA; TUMOR CELLS, CULTURED;

EID: 0036044460     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.1.1.46     Document Type: Note

References (18)

1. Raff MC. Social controls on cell survival and cell death. Nature 1992; 356:397-400.
2. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267:1456-1462.
3. Reed JC. Apoptosis-regulating proteins as targets for drug discovery. Trends Mol Med 2001; 7:314-319. (Pubitemid 32606571)
4. Ashkenazi A, Dixit, VM. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 1999; 11:255-260. (Pubitemid 29164042)
5. Kischkel FC, Lawrence, DA, Tinel, A, et al. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem 2001; 2:2.
6. Kohno T, Morishita, K, Takano, H, et al. Homozygous deletion at chromosome 2q33 in human small-cell lung carcinoma identified by arbitrarily primed PCR genomic fingerprinting. Oncogene 1994; 9:103-108. (Pubitemid 24020939)
7. Virmani AK, Fong, KM, Kodagoda D, et al. Allelotyping demonstrates common and distinct patterns of chromosomal loss in human lung cancer types. Genes Chromosomes Cancer 1998; 21:308-319. (Pubitemid 28165038)
8. Robertson KD. DNA methylation, methyltransferases, and cancer. Oncogene 2001; 20:3139-3155. (Pubitemid 32553570)
9. Teitz T, Wei, T, Valentine, MB, et al. Caspase-8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 2000; 6:529-535. (Pubitemid 30305902)
10. Fulda S, Kufer MU, Meyer E, et al. Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene 2001; 20:5865-5877. (Pubitemid 32937956)
11. Joseph B, Ekedahl, J, Sirzen, F. Differences in expression of pro-caspases in small cell and non-small cell lung carcinoma. Biochem Biophys Res Commun 1999; 262:381-387. (Pubitemid 29429877)
12. Grenet J, Teitz, T, Wei, T, et al. Structure and chromosome localization of the human CASP8 gene. Gene 1999; 226:225-232. (Pubitemid 29087103)
13. Kischkel FC, Lawrence, DA, Chuntharapai, A, et al. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 2000; 12:611-620.
14. Almasan A, Yin Y, Kelly RE, et al. Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc Natl Acad Sci USA 1995; 92:5436-5440.
15. Sherr CJ. Cancer cell cycles. Science 1996; 274:1672-1677.
16. Sherr CJ. The Pezcoller lecture: Cancer cell cycles revisited. Cancer Res 2000; 60:3689-3695. (Pubitemid 32204552)
17. Dosaka-Akita H, Cagle PT, Hiroumi H, et al. Differential retinoblastoma and p16(INK4A) protein expression in neuroendocrine tumors of the lung. Cancer 2000; 88:550-556. (Pubitemid 30056928)
18. Fisher MJ, Virmani AK, Wu L, et al. Nucleotide substitution in the ectodomain of TRAIL receptor DR4 is associated with lung cancer and head and neck cancer. Clin Cancer Res 2001; 7:1688-1697. (Pubitemid 32708637)